Digital health company partners with NHS trust

Digital therapies provider Ampersand Health has partnered with Worcestershire Acute Hospitals NHS Trust to roll out its inflammatory bowel disease (IBD) platform. 

My IBD Care supports patients living with Crohn’s disease and ulcerative colitis and helps with remote monitoring and communications between patients and clinicians.

The app helps individuals to better self-manage their IBD, bringing together a personal health record, medication and appointment reminders, daily lifestyle tracking and a library of wellbeing courses.

The platform will help support 2,800 IBD patients managed by the trust, as well as its clinicians, including consultant gastroenterologists, nurses and colorectal surgeons.

My IBD Care was developed in partnership with patient support group Crohn’s and Colitis UK, clinicians from King’s College Hospital NHS Foundation Trust and Barts Health NHS Trust, as well as patients.

‘Patients living with Crohn’s disease and ulcerative colitis can face personal challenges every day, from managing often painful symptoms and monitoring their diet, to dealing with sleep disruption and psychological stress,’ said Helen Osinski, IBD advanced nurse practitioner at Worcestershire NHS Trust.

‘Innovative new tools like My IBD Care are an essential part of the future of long-term condition care.’

Nader Alaghband, founder and CEO of Ampersand Health, added: ‘Covid-19 has placed unparalleled pressure upon the NHS and part of our role as healthtech innovators is to see how we can best help improve clinical capacity and hospital efficiency.’

Last month, Ampersand launched its My Arthritis DTx app to help people living with inflammatory arthritis to self-manage their condition. The platform has been implemented at University Hospitals Dorset.